Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
When Congress created Medicare Part D, it barred coverage of drugs used for weight loss, which were then considered unsafe, ineffective or both
Think about what just happened: In exchange for agreeing to the $249 monthly price, the only two manufacturers of GLP-1s, Novo Nordisk and Eli Lilly, received guaranteed access to the largest single payer patient population in the United States
F., Burgard, P., and Kolker, S
J Neuroimmunol
Moreover, while sCT was effective in suppressing body weight for 20-days, it lost its potency during the last 10 days
Retrieved from Centers for Disease Control and Prevention
US$ 26.65
US$ 20.85
US$ 26.08
US$ 29.53
